News

ARC Regulatory announces the appointment of Chief Operating Officer

March 12, 2024

ARC regulatory announces new member of staff

Belfast, UK – 11 March 2024 – ARC Regulatory is pleased to confirm the appointment of a newly created role of Chief Operating Officer.

ARC, established in 2010, delivers integrated solutions to the Precision Medicine sector, supporting the implementation and compliant research of in vitro diagnostics (IVD) in precision medicine trials worldwide. The company’s mission is to be the preferred partner for the global precision medicine and IVD industry, supporting the development of kinder treatments and expediting the highest quality clinical research for improved patient outcomes.

They join the company to provide ongoing oversight, delivery and improvement of company operations and customer success. He will pursue operational excellence during its next stage of high-growth. With extensive experience in the health and life sciences sector, having previously held senior leadership roles at Solvay Healthcare, Encysive Pharmaceuticals, Pharmaxis and Pfizer.

Seamus Kearney, Founder and CEO of ARC, commented: "I am delighted to expanded senior leadership team as we continue our mission to deliver kinder patient treatments.”

To learn more about opportunities to join ARC’s team, contact [email protected]